NEW ENTERPRISE ASSOCIATES 15, L.P. / RENEO PHARMACEUTICALS, INC. -- SCHEDULE 13D

Company

OnKure Therapeutics, Inc.

Filed

April 23, 2021

Accession Number

0001072613-21-000379

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →